A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this ...

Asymptomatic and pre-symptomatic individuals primarily drive the coronavirus disease 2019 (COVID-19) pandemic by unknowingly transmitting the virus to others. Asymptomatics are those infected people ...

SHANGHAI, July 8, 2021 /PRNewswire/ -- As is known, nucleic acid detection is currently the "golden standard" of coronavirus detection and has the high sensitivity and specificity characteristics in ...

Expands Aegea Biotechnologies' Intellectual Property for Methods of Detecting Rare Genetic Events and for Methods to Improve PCR Amplification Reactions; Applicable to Coronavirus (COVID-19) Molecular ...

Technology development focused on generating tools to advance nucleic acid-based research for functional genomics and gene-expression analysis to drive drug discovery and development and to develop ...

Chinese researchers have developed a new nucleic acid test kit for COVID-19, which can confirm cases in 45 minutes on average, according to the Suzhou Institute of Biomedical Engineering and ...

BEIJING, Aug 6, 2020 - (ACN Newswire) - - Changzhou Biowin Pharmaceutical Co., Ltd. ("Biowin"), a Chinese biotech company focusing on diagnostic product R&D and high-tech biomedical manufacturing, has ...

Featuring flexibility and portability, the two products are ideal for small laboratories or on-site testing needs. "We know that throughput waste and lack of space are two common concerns for many ...

IRVINE, Calif., April 26, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical ...